IPOPLUS

₹4,442.8

▼ -23.9 -0.54%

18 Jun 2026

NSE Listed · Pharmaceuticals

Torrent Pharmaceuticals Limited (TORNTPHARM)

Volume: 5,798Avg Vol 1W: 12,072Avg Vol 1M: 14,21252W Range:₹3,140.1₹4,712.9
NSE BSE
₹4,442.8▼ 0.54%
Key Ratios
Updated 6h ago
Market Cap₹1,51,099 Cr
Current Price₹4,442.8
Previous Close₹4,466.7
High / Low (52w)₹4,712.9 / ₹3,140.1
Volume5,798
Avg Vol (1W)12,072
Avg Vol (1M)14,212
Stock P/E—
Book Value₹247.86
Dividend Yield0.83%
ROE25.49%
ROA4.82%
Revenue (TTM)—
Revenue Growth21.39%
Profit Margin15.55%
Total Debt₹11,651 Cr
Shares Outstanding34 Cr
Face Value₹5
EPS (TTM)₹11.51
P/B18.01
Debt / Equity1.79
50 DMA₹4,349.84
200 DMA₹4,185.15
Day change-0.54%
Price Chart
₹4,442.8▲ 24.61% · 1Y
₹4575₹343716.4L
2025-10-01
2026-06-16

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 25.5%.
  • Company is almost debt-free.
  • Revenue grew 20% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹4,197 Cr₹3,303 Cr₹3,302 Cr₹3,178 Cr₹2,959 Cr₹2,809 Cr₹2,889 Cr₹2,859 Cr₹2,745 Cr₹2,732 Cr₹2,660 Cr₹2,591 Cr₹2,491 Cr₹2,491 Cr₹2,291 Cr₹2,347 Cr₹2,131 Cr₹2,108 Cr₹2,137 Cr₹2,134 Cr₹1,937 Cr₹1,995 Cr₹2,017 Cr₹2,056 Cr₹1,946 Cr
EBITDA₹831 Cr₹869 Cr₹852 Cr₹794 Cr₹745 Cr₹748 Cr₹725 Cr₹731 Cr₹711 Cr₹623 Cr₹650 Cr₹634 Cr₹540 Cr₹521 Cr₹532 Cr₹587 Cr₹455 Cr₹419 Cr₹543 Cr₹552 Cr₹456 Cr₹448 Cr₹476 Cr₹504 Cr₹395 Cr
Net Profit₹364 Cr₹635 Cr₹591 Cr₹548 Cr₹498 Cr₹503 Cr₹453 Cr₹457 Cr₹449 Cr₹443 Cr₹386 Cr₹378 Cr₹287 Cr₹292 Cr₹312 Cr₹354 Cr₹-118 Cr₹249 Cr₹316 Cr₹330 Cr₹324 Cr₹297 Cr₹310 Cr₹321 Cr₹314 Cr
EPS11.5118.7717.5416.1914.7114.8813.3713.5113.2713.111.3911.188.488.639.2220.9-6.9714.7518.6319.5319.1617.5218.3218.9818.56
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹13,886 Cr₹11,539 Cr₹10,786 Cr₹9,665 Cr₹8,705 Cr₹8,061 Cr₹8,061 Cr
EBITDA₹3,346 Cr₹2,949 Cr₹2,617 Cr₹2,181 Cr₹1,966 Cr₹1,879 Cr₹1,637 Cr
Net Profit₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr
EPS63.9256.4748.9436.7922.9673.9860.55
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹44,312 Cr₹14,990 Cr₹15,061 Cr₹15,012 Cr₹13,100 Cr₹14,075 Cr₹14,010 Cr
Total Liabilities₹26,727 Cr₹7,399 Cr₹8,204 Cr₹8,814 Cr₹7,147 Cr₹8,237 Cr₹9,187 Cr
Equity₹17,585 Cr₹7,591 Cr₹6,856 Cr₹6,198 Cr₹5,953 Cr₹5,837 Cr₹4,823 Cr
Total Debt₹11,651 Cr₹1,192 Cr₹1,604 Cr₹2,496 Cr₹2,123 Cr₹2,941 Cr₹3,275 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹3,832 Cr₹3,188 Cr₹3,764 Cr₹2,766 Cr₹2,224 Cr₹2,181 Cr₹1,677 Cr
Investing₹-12,712 Cr₹-540 Cr₹-168 Cr₹-2,415 Cr₹-197 Cr₹-449 Cr₹199 Cr
Financing₹10,151 Cr₹-2,298 Cr₹-2,780 Cr₹77 Cr₹-1,781 Cr₹-1,651 Cr₹-1,549 Cr
Free Cash Flow₹3,832 Cr₹3,188 Cr₹3,764 Cr₹2,766 Cr₹2,224 Cr₹2,181 Cr₹1,677 Cr
Shareholding
Promoter 68.31% Institutions 25.24% Public 6.45%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search